INmune Bio, Inc. (INMB) Tops Q3 EPS by 9c
INmune Bio, Inc. (NASDAQ: INMB) reported Q3 EPS of ($0.24), $0.09 better than the analyst estimate of ($0.33).
For earnings history and earnings-related data on INmune Bio, Inc. (INMB) click here.
INmune Bio, Inc. (NASDAQ: INMB) reported Q3 EPS of ($0.24), $0.09 better than the analyst estimate of ($0.33).
For earnings history and earnings-related data on INmune Bio, Inc. (INMB) click here.